[Skip to Content]
[Skip to Content Landing]
Other Articles
February 11, 1939

SULFAPYRIDINE IN THE TREATMENT OF PNEUMONIA

Author Affiliations

New York.

New York.

Boston.

JAMA. 1939;112(6):570. doi:10.1001/jama.1939.02800060086024

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor:—  In recent years many agents, chemical, physical and biologic, have been recommended for the treatment of pneumonia. In each instance the early experiences were brilliant, marked reductions in death rates and striking therapeutic responses being noted. Quinine and its derivatives, intravenous dextrose, nonspecific protein therapy, vaccines, diathermy, pneumothorax and, most recently, deuteroproteose and roentgen therapy are only a few of those which might be mentioned. In most instances the early reports considered too few cases and did not take into account the most important factors influencing the mortality in this disease. Individual cases or small groups of clinical results were reported with great enthusiasm.The value of some of these agents even now has not been properly assessed. In most instances, however, closer scrutiny and further observations under controlled conditions have shown no particular virtues or life saving values for these various agents and they have not

First Page Preview View Large
First page PDF preview
First page PDF preview
×